Key Takeaways
- Huawei (HWT.UL – unofficial, as Huawei is not publicly traded) announced an aggressive roadmap for its Ascend and Atlas AI chips, with the Ascend 910C launched in Q1 2025 and new Ascend 950PR/950DT chips slated for 2026, alongside the Atlas 950 Supercluster in late 2025, aiming to bolster China's domestic AI computing power amidst U.S. restrictions.
- The UAE Central Bank cut its benchmark interest rate by 25 basis points to 4.15% on Wednesday, mirroring a move by the U.S. Federal Reserve and marking its first rate reduction in 2025.
- The HK Hang Seng Index surged past the 27,000 level, reaching a milestone not seen in over two years, indicating renewed investor confidence in the region.
- South Korea's Fair Trade Commission conditionally approved a joint venture between AliExpress Korea and a Shinsegae Group unit, a move expected to intensify competition in the domestic e-commerce market.
- Geopolitical tensions remain high as Iran's Foreign Minister engaged in talks with European nations regarding its nuclear program, while Poland urged the EU to impose a 2026 deadline for ending Russian oil imports.
In a series of significant financial and geopolitical developments, global markets are closely watching Huawei's ambitious chip rollout, a key interest rate cut in the UAE, and escalating diplomatic efforts concerning Iran's nuclear program and European energy security.
Huawei's Aggressive AI Chip Roadmap
Chinese tech giant Huawei (HWT.UL) is making substantial strides in its artificial intelligence (AI) chip development, with its Vice Chairman confirming plans for several new Ascend and Atlas series chips. The Ascend 910C chip was launched in the first quarter of 2025, with mass shipments expected by May 2025, positioning it as a domestic alternative to Nvidia's (NVDA) restricted H20 chip. Despite U.S. sanctions, Huawei aims to mass-produce the Ascend 910C in Q1 2025, though it faces challenges with a reported yield rate of around 20% from SMIC's N+2 process, significantly below the commercially viable threshold.
Looking ahead, Huawei plans to release the Ascend 950PR and Ascend 950DT chips in 2026. The company's Atlas 950 Supercluster, touted as the world's most powerful computing cluster, is expected to launch in late 2025. Further expanding its portfolio, the Ascend 960 and Ascend 270 chips are slated for 2027 and 2028 respectively, with the next-generation Atlas 960 also expected in Q4 2027. Huawei emphasizes its commitment to sustainably supporting AI's rapid, long-term development through "Supernode + Cluster" solutions built using China’s domestic chipmaking capabilities.
UAE Interest Rate Cut and Market Movements
The Central Bank of the UAE (CBUAE) announced a 25 basis point reduction in its benchmark interest rate, lowering the Overnight Deposit Facility (ODF) rate from 4.40% to 4.15%, effective Thursday. This decision closely follows a similar rate cut by the U.S. Federal Reserve, which the CBUAE mirrored due to the UAE dirham's peg to the U.S. dollar. The move comes as the UAE slightly revised down its inflation forecast for 2025 to 1.9% from 2%, and for 2026 to 1.9% from 2.1%.
Meanwhile, the HK Hang Seng Index demonstrated robust performance, breaking above the 27,000 level for the first time in over two years. This surge reflects positive market sentiment in the Asia-Pacific region.
South Korea E-commerce Joint Venture Approved
In South Korea, the Fair Trade Commission (FTC) has conditionally approved a joint venture between AliExpress Korea, a unit of Alibaba International (BABA), and a unit of Shinsegae Group. The joint company, named "Grand Opus Holding," will see Emart affiliate Apollo Korea contribute 100% equity in Gmarket, while Alibaba affiliate BK4 invests $225 million in cash along with 100% equity in AliExpress Korea. This merger is anticipated to significantly reshape the domestic e-commerce landscape, potentially leading to a three-way competition structure with Coupang (CPNG) and Naver (035420.KS). The FTC's conditional approval addresses concerns over potential competition restrictions, particularly in the overseas direct purchase market where AliExpress holds a high share.
Geopolitical Developments
Geopolitical discussions continue to unfold on several fronts. Iranian Foreign Minister Abbas Araghchi held a call with British, French, and German foreign ministers to discuss Tehran's nuclear program, aiming to avert the re-imposition of international sanctions. These talks follow a recent agreement between Iran and the International Atomic Energy Agency (IAEA) to resume cooperation, including site inspections, amidst concerns over Iran's enriched uranium stocks following Israeli and U.S. strikes in June. However, diplomats indicate that little progress was made in these discussions, with Europe's 30-day ultimatum for Iran to meet conditions to delay the "snapback mechanism" looming.
In Europe, Poland is actively pushing the EU for a 2026 deadline to halt Russian oil imports, citing rising geopolitical risks and the need to cease financing Russia's war machine. While the EU has proposed a gradual phase-out of Russian fossil fuels by the end of 2027, with new gas contracts prohibited from January 2026 and existing short-term contracts by June 2026, Poland seeks an earlier, more definitive timeline. Separately, the Syrian Foreign Minister is scheduled to discuss U.S. sanctions relief in Washington this week, according to Axios.
Fitch Rating and CDC Vaccine Discussions
Fitch Ratings has published an ‘AAA’ rating on the Federal International Finance Programme VII Tranche II Bonds, reflecting strong credit quality.
In public health news, the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is scheduled to vote on guidance for hepatitis B and MMRV (measles, mumps, rubella, and varicella) vaccines. Discussions include a potential recommendation to delay the hepatitis B vaccine for newborns until age four, a move that has drawn concern from pediatricians who warn it could lead to a resurgence of the disease. The committee, recently reconstituted by Health and Human Services Secretary Robert F. Kennedy Jr. with members described as skeptical of traditional vaccine policies, is also reviewing guidance against the MMRV vaccine for children under four due to a slightly higher risk of febrile seizures in younger toddlers.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.